Literature DB >> 15886711

Mitochondrial DNA and ACTN3 genotypes in Finnish elite endurance and sprint athletes.

Anna-Kaisa Niemi1, Kari Majamaa.   

Abstract

Differences in ACTN3 (alpha-actinin 3) genotypes have been reported among endurance and power athletes. Elite athletic performance in endurance sports should also depend on mitochondrial oxidative phosphorylation (OXPHOS) that produces ATP for muscle metabolism. We determined mitochondrial DNA (mtDNA) and ACTN3 genotypes in Finnish elite endurance (n = 52) and sprint (n = 89) athletes, and found that the frequencies of mtDNA haplogroups differed significantly between the two groups. Most notably, none of the endurance athletes belonged to haplogroup K or subhaplogroup J2, both of which have previously been associated with longevity. The frequency of ACTN3 XX genotype was higher and that of RR was lower among Finnish endurance athletes, and, in addition, none of the top Finnish sprinters had the XX genotype. Lack of mtDNA haplogroup K and subhaplogroup J2 among elite endurance athletes suggests that these haplogroups are 'uncoupling genomes'. Such genomes should not be beneficial to endurance-type athletic performance but should be beneficial to longevity, since uncoupling of OXPHOS reduces the production of ATP, reduces the release of reactive oxygen species and generates heat.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15886711     DOI: 10.1038/sj.ejhg.5201438

Source DB:  PubMed          Journal:  Eur J Hum Genet        ISSN: 1018-4813            Impact factor:   4.246


  67 in total

Review 1.  Animal models of muscular dystrophy.

Authors:  Rainer Ng; Glen B Banks; John K Hall; Lindsey A Muir; Julian N Ramos; Jacqueline Wicki; Guy L Odom; Patryk Konieczny; Jane Seto; Joel R Chamberlain; Jeffrey S Chamberlain
Journal:  Prog Mol Biol Transl Sci       Date:  2012       Impact factor: 3.622

Review 2.  Genes, environment and sport performance: why the nature-nurture dualism is no longer relevant.

Authors:  Keith Davids; Joseph Baker
Journal:  Sports Med       Date:  2007       Impact factor: 11.136

Review 3.  The genetics of sports injuries and athletic performance.

Authors:  Nicola Maffulli; Katia Margiotti; Umile Giuseppe Longo; Mattia Loppini; Vito Michele Fazio; Vincenzo Denaro
Journal:  Muscles Ligaments Tendons J       Date:  2013-08-11

Review 4.  Genomics and genetics in the biology of adaptation to exercise.

Authors:  Claude Bouchard; Tuomo Rankinen; James A Timmons
Journal:  Compr Physiol       Date:  2011-07       Impact factor: 9.090

Review 5.  Mitochondria as chi.

Authors:  Douglas C Wallace
Journal:  Genetics       Date:  2008-06       Impact factor: 4.562

Review 6.  Genes and elite athletes: a roadmap for future research.

Authors:  Nir Eynon; Jonatan R Ruiz; José Oliveira; José Alberto Duarte; Ruth Birk; Alejandro Lucia
Journal:  J Physiol       Date:  2011-05-03       Impact factor: 5.182

Review 7.  Genetic aspects of skeletal muscle strength and mass with relevance to sarcopenia.

Authors:  Stephen M Roth
Journal:  Bonekey Rep       Date:  2012-04-04

8.  ACTN3 genotype influences muscle performance through the regulation of calcineurin signaling.

Authors:  Jane T Seto; Kate G R Quinlan; Monkol Lek; Xi Fiona Zheng; Fleur Garton; Daniel G MacArthur; Marshall W Hogarth; Peter J Houweling; Paul Gregorevic; Nigel Turner; Gregory J Cooney; Nan Yang; Kathryn N North
Journal:  J Clin Invest       Date:  2013-09-16       Impact factor: 14.808

9.  Mitochondrial DNA Haplogroups and Susceptibility to Neuroblastoma.

Authors:  Xiao Chang; Marina Bakay; Yichuan Liu; Joseph Glessner; Komal S Rathi; Cuiping Hou; Huiqi Qu; Zalman Vaksman; Kenny Nguyen; Patrick M A Sleiman; Sharon J Diskin; John M Maris; Hakon Hakonarson
Journal:  J Natl Cancer Inst       Date:  2020-12-14       Impact factor: 13.506

10.  Citius and longius (faster and longer) with no alpha-actinin-3 in skeletal muscles?

Authors:  Alejandro Lucia; Jesús Oliván; Félix Gómez-Gallego; Catalina Santiago; Marta Montil; Carl Foster
Journal:  Br J Sports Med       Date:  2007-02-08       Impact factor: 13.800

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.